Neuraxis NRXS
NYSE NRXS
$5.67 -0.06 (-1.07%)
As of: Sep 10, 2026 · 12:34 PM EDT

Neuraxis (NRXS) EBT Margin (2022 - 2025)

Neuraxis' (NRXS) quarterly EBT Margin came in at 180.3% in Q4 2025, up 1238.0% year-over-year from 13.48% in Q4 2024, and up 31.31% quarter-over-quarter from 262.47% in Q3 2025.

Analysis

Neuraxis (NRXS) EBT Margin (2022 - 2025) Analysis & Trends

Neuraxis has disclosed EBT Margin across 4 years of filings, most recently posting 180.3% for Q4 2025.

  • In Q4 2025, EBT Margin rose 1238.0% year-over-year to 180.3%; the TTM figure through Dec 2025 stood at 221.44% (up 6989.0% YoY), while the FY2025 annual figure was 221.44%, up 6683.0% from the prior year.
  • EBT Margin came in at 180.3% for Q4 2025 at Neuraxis, up from 262.47% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 103.14% in Q2 2022 to a low of 654.06% in Q3 2023.
  • Average EBT Margin over 4 years is 258.95%, with a median of 210.71% recorded in 2022.
  • Year-over-year, EBT Margin slumped 44335 bps in 2023 and soared 39665 bps in 2024.
  • Over 4 years, EBT Margin stood at 186.53% in 2022, then tumbled by 66 bps to 309.67% in 2023, then soared by 38 bps to 192.68% in 2024, then gained by 6 bps to 180.3% in 2025.
  • Per Business Quant data, the three most recent EBT Margin figures were 180.3% in Q4 2025, 262.47% in Q3 2025, and 193.64% in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn 12.10%
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn 36.46%
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn 18.13%
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn 23.74%
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn 19.48%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 29.86%
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -1.65%
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn 24.27%
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn 18.32%
10 Neuraxis 68.70 Mn 60.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -180.30%
Sep 30, 2025 -262.47%
Jun 30, 2025 -193.64%
Mar 31, 2025 -256.50%
Dec 31, 2024 -192.68%
Sep 30, 2024 -257.41%
Jun 30, 2024 -455.23%
Mar 31, 2024 -287.44%
Dec 31, 2023 -309.67%
Sep 30, 2023 -654.06%
Jun 30, 2023 -203.13%
Mar 31, 2023 -131.41%
Dec 31, 2022 -186.53%
Sep 30, 2022 -210.71%
Jun 30, 2022 -103.14%